Navigation Links
Study reveals mass migration of mormon crickets driven by hunger, fear

An international team of researchers, including Kent State University professor Dr. Patrick D. Lorch, have revealed the motivating factors behind the seasonal mass migration of Mormon crickets in western North America.

The scientists report hunger for protein and salt, and a fear of cannibalism, drives the mass migration of Mormon crickets in western North America.

Throughout their seasonal migration, millions of Mormon crickets (relatives of locusts and grasshoppers) cover more than 50 miles of ground, destroying farmland and causing hazardous driving conditions along the way.

The research team, led by Dr. Stephen J. Simpson, conducted field observations and experimentation to determine that two driving forces are behind the migration: a need for protein and a fear of cannibalism.

Their results reveal a different model for collective motion, with the crickets' migration in effect a forced march. The constant threat of cannibalism from the rear appears to push the crickets' movement as much as the need to find protein and salt pulls it, researchers say.

The team's findings could lead to more environmentally friendly tactics for controlling large swarms of insects.


'"/>

Source:Kent State University


Page: 1

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
4. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
5. Study Links Ebola Outbreaks To Animal Carcasses
6. Breakthrough Microarray-based Technology for the Study of Cancer
7. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
8. Study finds more than one-third of human genome regulated by RNA
9. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
10. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
11. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/25/2017)... NEW YORK , Jan. 25, 2017 /PRNewswire/ ... and Access Management (IAM) lifecycle is comprised of ... infrastructure for the purpose of maintaining digital identities ... enterprise resources and applications. There are significant number ... compliance from time to time by optimizing processes ...
(Date:1/19/2017)... , January 19, 2017 According to a new ... and Forecast, 2014 - 2022," the global biometric sensor market is expected to ... to 2022. In 2015, Asia-Pacific dominated the global market ... private sectors. Continue Reading ... ...
(Date:1/12/2017)... , Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... DNA (ctDNA) technologies, today announced that it has signed ... and the Middle East ...  This milestone marks the first wave of international distribution ... urine and blood samples. The initial partners ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... -- Research and Markets has announced the ... report to their offering. ... The study scope ... plasmids, chassis organisms, synthetic cells, production systems), enabling technologies ... and specialty media) and enabled technologies (biofuels, chemicals, pharmaceuticals, ...
(Date:2/16/2017)... HOLLISTON, Mass. , Feb. 16, 2017   ... or the "Company"), a biotechnology company developing bioengineered organ ... the esophagus, bronchus and trachea, announced today the closing ... offering of 20,000,000 shares of common stock and warrants ... gross proceeds of $8.0 million. The offering was priced ...
(Date:2/16/2017)... , Feb. 16, 2017 UCHealth ( ... to utilize LungDirect for pulmonary nodule patient management. In ... nodule, or a spot on the lung, UCHealth looks ... on manual data entry. Stephanie Brown, ... tracking my nodule patients with an Excel spreadsheet, which ...
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
Breaking Biology Technology: